Approval · Notice of Compliance 22709 · 2019
AUBAGIO: Notice of Compliance 22709
Issued September 26, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22709
- Date
- September 26, 2019
- Company
- Sanofi Genzyme, A Division Of Sanofi-Aventis Canada IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To add pharmacokinetic data from two pediatric patients to the product monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AUBAGIO | Not yet assigned | — |
Medicinal ingredients
- TERIFLUNOMIDE 14 MG per TAB